Photo of Brian Tully McLaughlinPhoto of Jason CrawfordPhoto of Stephen M. ByersPhoto of Lyndsay GortonPhoto of Amanda McDowell

Next Tuesday, April 18, 2023, the highest court in the land will hear arguments in what is poised to be the most influential False Claims Act (FCA) case since the landmark decision in Universal Health Servs. v. United States ex rel. Escobar, 136 S. Ct. 1989 (2016).  On January 13, 2023, the U.S. Supreme Court granted certiorari to hear two consolidated appeals from the U.S. Court of Appeals for the Seventh Circuit in United States ex rel. Schutte v. SuperValu Inc., 9 F.4th 455 (7th Cir. 2021) and United States ex rel. Proctor v. Safeway, Inc., 30 F.4th 649 (7th Cir. 2022).  The Court’s decision will likely have far-reaching ramifications for FCA cases involving ambiguous contractual or regulatory requirements and may also provide benchmarks for assessing the key element of scienter across all FCA cases.  

In Supervalu and Safeway, the Seventh Circuit joined several of its sister circuits in applying the scienter standard articulated by the Supreme Court in Safeco Insurance Company of America v. Burr, 551 U.S. 47 (2007) to the FCA, finding that a defendant’s conduct is not reckless when (1) acting under an objectively reasonable, albeit erroneous, interpretation of an ambiguous regulation or contract provision; and (2) no authoritative guidance existed to warn the defendant away from that interpretation.

The petition to the Supreme Court urged the Justices to resolve an alleged circuit split on the proper scienter standard under the FCA, including whether a defendant should be entitled in litigation to rely upon an interpretation that it may not have actually relied upon when it submitted the claims.  The Supreme Court’s forthcoming ruling will undoubtedly have significant implications for all manner of FCA cases, from health care to procurement fraud and more, and as a result is one to watch closely.

In the cases before the Court, relators filed qui tam suits alleging that the defendants knowingly caused false claims to be submitted to government healthcare programs.  The Government declined to intervene in either case.  Applying Safeco, the district court in each action held that the defendants’ interpretation of underlying legal requirements, while incorrect, was objectively reasonable and that no authoritative guidance had warned against this interpretation.  On appeal, the Seventh Circuit agreed with the district court’s application of the Safeco standard to the FCA, concluding that Safeco’s rule with respect to ambiguous provisions is narrow enough so as not to “shield bad faith defendants that turn a blind eye” to wrongful practices.  At the same time, the Seventh Circuit found that scienter in cases like these can be determined without a separate inquiry into the defendant’s subjective intent because the test is an objective one.  Applying the Safeco standard, the Seventh Circuit affirmed the district court rulings that the defendants did not act “knowingly” under the FCA.

Judge Hamilton sat on each panel and dissented in both cases.  He argued that the majority improperly disregarded the defendants’ subjective intent as irrelevant to the question of whether their interpretation was objectively reasonable.  In Judge Hamilton’s view, where a defendant “knew at the time that it was carrying out a fraud and needed to conceal it,” the defendant should not be able to escape liability by later offering an objectively reasonable interpretation of the law to justify its conduct.  In the face of evidence of nefarious and deceptive intent, Judge Hamilton posited that the FCA’s scienter requirement is fulfilled, regardless of any subsequently-claimed reasonable interpretation of the law.

The relators in both cases filed petitions for certiorari in April 2022.  In their respective Briefs in Opposition to the relators’ petitions, the respondent defendants contended that Safeco does not lower the bar for compliance; rather, it recognizes that it is impossible to have knowledge of the correct interpretation of an ambiguous legal obligation before the government has authoritatively announced its interpretation or a court has made such a determination.  In contrast, a defendant that engages in objectively unreasonable conduct even in the face of an uncertain legal obligation, or acts contrary to an authoritative interpretation of an ambiguous regulation or rule, will still be subject to liability under the FCA, and nothing about Safeco changes that.  In short, respondents argued that “Safeco does not give a free pass to cheats and fraudsters, nor make ignorance of the law a defense.  It merely protects those that ‘cannot know that [their] claim is false’ because ‘the requirements for that claim are unknown.’”

Senator Chuck Grassley (R-IA)—the principal author of the 1986 amendments that gave rise to the modern FCA—filed an amicus curiae brief in support of the relators urging the Supreme Court to grant certiorari and vacate the decision of the Seventh Circuit.  Senator Grassley argued that the Safeco standard “makes a hash of the law of fraud,” noting that it “places the burden on the Government to anticipate every possible fraud” and endlessly issue “definitive guidance” to proscribe that fraud.  What results, according to Senator Grassley, is a scenario in which a defendant who “correctly knows an act is unlawful is immunized from FCA liability if its lawyer, years later, can cook up an interpretation of the law under which the act was arguably permissible—even if that interpretation is wrong and the defendant did not have that interpretation at the time.”  This amicus brief is another example of Senator Grassley’s full-throated objection to what he deems the gradual judicial curbing of the power of the FCA, resulting in what he terms a “free pass to fleece the public fisc.”  Senator Grassley’s amicus brief kicked off a string of other amicus briefs on both sides ranging from private organizations and healthcare businesses to states and federal agencies. 

The Solicitor General also filed an amicus brief, urging the Supreme Court to grant certiorari and arguing that the FCA’s scienter standard is fulfilled where a defendant: (i) subjectively believes that a claim is false; (ii) recognizes a substantial risk that the claim is false but deliberately avoids taking readily available steps to obtain clarification; or (iii) knows or should know that the claim is probably false but acts with reckless disregard of that danger. 

Briefing is now complete and nearly twenty amicus briefs have been submitted between the competing sides.  Going into next Tuesday’s argument, the Supreme Court has scheduled a total of one hour for the argument, with 20 minutes allotted to relator-petitioners, 10 minutes for the Solicitor General, and 30 minutes for defendant-respondents.

We think it probable that the Supreme Court will not waiver from the circuit courts’ endorsement of the Safeco standard to FCA cases generally, but how the Court will resolve questions regarding evidence of subjective versus objective interpretations of ambiguous requirements is much more difficult to predict.  What is “objectively” certain, though, is that the Supreme Court’s ruling will have an enormous impact as to the critical element of scienter in all manner of FCA investigations and litigation.  We continue to monitor these cases closely and will report our reactions following next week’s oral arguments.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Brian Tully McLaughlin Brian Tully McLaughlin

Brian Tully McLaughlin is a partner in the Government Contracts Group in Washington, D.C. and co-chair of the False Claims Act Practice. Tully’s practice focuses on False Claims Act investigations and litigation, particularly trial and appellate work, as well as litigation of a…

Brian Tully McLaughlin is a partner in the Government Contracts Group in Washington, D.C. and co-chair of the False Claims Act Practice. Tully’s practice focuses on False Claims Act investigations and litigation, particularly trial and appellate work, as well as litigation of a variety of complex claims, disputes, and recovery matters. Tully’s False Claims Act experience spans procurement fraud, healthcare fraud, defense industry fraud, and more. He conducts internal investigations and represents clients in government investigations who are facing fraud or False Claims Act allegations. Tully has successfully litigated False Claims Act cases through trial and appeal, both those brought by whistleblowers / qui tam relators and the Department of Justice alike. He also focuses on affirmative claims recovery matters, analyzing potential claims and changes, counseling clients, and representing government contractors, including subcontractors, in claims and disputes proceedings before administrative boards of contract appeals and the Court of Federal Claims, as well as in international arbitration. His claims recovery experience includes unprecedented damages and fee awards. Tully has appeared and tried cases before judges and juries in federal district courts, state courts, and administrative boards of contract appeals, and he has argued successful appeals before the D.C. Circuit, the Federal Circuit, and the Fourth and Seventh Circuits.

Photo of Jason Crawford Jason Crawford

When facing government investigations or high stakes litigation, clients trust Jason Crawford to evaluate allegations, identify risks, and formulate strategies to achieve the appropriate resolution. Jason advises and advocates for government contractors and companies from regulated industries in matters involving civil, criminal, and…

When facing government investigations or high stakes litigation, clients trust Jason Crawford to evaluate allegations, identify risks, and formulate strategies to achieve the appropriate resolution. Jason advises and advocates for government contractors and companies from regulated industries in matters involving civil, criminal, and administrative enforcement, with a particular focus on the False Claims Act (FCA).

As a litigator, Jason has defended government contractors, drug manufacturers, grant recipients, health care companies, importers, and construction companies sued under the FCA by whistleblowers and the Department of Justice (DOJ) in federal courts throughout the country. He also helps clients conduct complex internal investigations and respond strategically to Office of Inspectors General inquiries, grand jury investigations, search warrants, and civil investigative demands.

Jason previously served as a DOJ Trial Attorney in the Civil Division, Fraud Section where he investigated and litigated FCA cases involving government contractors, importers, and health care companies. He also previously worked with the U.S. Attorney’s Office for the District of Columbia where he prosecuted federal criminal cases.

A recognized thought leader on FCA developments, Jason has written and presented extensively on the fraud statute, and he is a co-host of the Let’s Talk FCA podcast.

Photo of Stephen M. Byers Stephen M. Byers

Stephen M. Byers is a partner in the firm’s White Collar & Regulatory Enforcement Group and serves on the group’s steering committee. He is also a member of the firm’s Government Contracts Group and E-Discovery & Information Management Group. Mr. Byers’s practice involves…

Stephen M. Byers is a partner in the firm’s White Collar & Regulatory Enforcement Group and serves on the group’s steering committee. He is also a member of the firm’s Government Contracts Group and E-Discovery & Information Management Group. Mr. Byers’s practice involves counseling and representation of corporate and individual clients in all phases of white collar criminal and related civil matters, including: internal corporate investigations; federal grand jury, inspector general, civil enforcement and congressional investigations; and trials and appeals.

Mr. Byers’s practice focuses on matters involving procurement fraud, health care fraud and abuse, trade secrets theft, foreign bribery, computer crimes and cybersecurity, and antitrust conspiracies. He has extensive experience with the federal False Claims Act and qui tam litigation, the Foreign Corrupt Practices Act, the Economic Espionage Act, and the Computer Fraud and Abuse Act. In addition to defense of government investigations and prosecutions, Mr. Byers has represented corporate victims of trade secrets theft, cybercrime, and other offenses. For example, he represented a Fortune 100 U.S. company in parallel civil and criminal proceedings that resulted in a $275 million criminal restitution order against a foreign competitor upon its conviction for trade secrets theft.

Photo of Lyndsay Gorton Lyndsay Gorton

Lyndsay Gorton is a Government Contracts counsel in Crowell & Moring’s Washington, D.C. office. Her practice focuses on government contracts litigation and counseling, including government investigations, fraud matters under the False Claims Act, bid protests, and federal and state regulatory compliance. In addition…

Lyndsay Gorton is a Government Contracts counsel in Crowell & Moring’s Washington, D.C. office. Her practice focuses on government contracts litigation and counseling, including government investigations, fraud matters under the False Claims Act, bid protests, and federal and state regulatory compliance. In addition to her primary government contracts practice, Lyndsay has federal court litigation experience representing a broad variety of clients in commercial litigation matters, and has led and managed teams at every stage of litigation, including discovery, dispositive motion practice, trial, and settlement. She also uses her litigation experience to assist her clients with internal investigations, risk management, and compliance.

Photo of Amanda McDowell Amanda McDowell

Amanda H. McDowell is an associate in the Government Contracts and Health Care groups in Crowell & Moring’s Washington, D.C. office. Amanda represents contractors in litigation, regulatory, and counseling matters. Her practice focuses on False Claims Act litigation, government investigations, bid protests, and…

Amanda H. McDowell is an associate in the Government Contracts and Health Care groups in Crowell & Moring’s Washington, D.C. office. Amanda represents contractors in litigation, regulatory, and counseling matters. Her practice focuses on False Claims Act litigation, government investigations, bid protests, and state and federal regulatory compliance.